Search articles from thousands of Examiners
Write for us
Columbia Business

Email Article

Gaithersburg’s MedImmune sold for $15.2 billion
Melissa Frederick, The Examiner
Apr 24, 2007 3:00 AM (961 days ago)Gaithersburg

Gaithersburg-based drug company MedImmune Inc. has been sold to a British pharmaceutical firm for $15.2 billion. MedImmune is the company behind the FluMist vaccine, among other ventures. In a statement Monday, AstraZenenca said the move will allow the company to expand its biotechnology business, adding 45 projects to the company’s pipeline.

http://www.examiner.com/a-691057~Gaithersburg_s_MedImmune_so ld_for__15_2_billion.html

The above excerpt and link will be sent by email.

 
Your Email:

Friend's Email (separated by commas):

Message (optional):